Preclinical News and Research

RSS
AMO Pharma raises $25 million in private equity financing

AMO Pharma raises $25 million in private equity financing

Leading cancer researchers address eight 'big questions'

Leading cancer researchers address eight 'big questions'

Researchers develop a technique that uses platelet membranes to coat anticancer drugs

Researchers develop a technique that uses platelet membranes to coat anticancer drugs

Collaborative approach may speed discovery of new preventive treatments for Alzheimer's disease

Collaborative approach may speed discovery of new preventive treatments for Alzheimer's disease

Disruption of blood-CSF barrier may negatively affect progression of Alzheimer's disease

Disruption of blood-CSF barrier may negatively affect progression of Alzheimer's disease

New self-contained device could provide instant results to routine lab tests, accelerate treatment and diagnosis

New self-contained device could provide instant results to routine lab tests, accelerate treatment and diagnosis

Unique molecule can bind HIV-infected cells to killer T cells

Unique molecule can bind HIV-infected cells to killer T cells

Mediso USA announces tenth site of integrated preclinical nanoScan systems

Mediso USA announces tenth site of integrated preclinical nanoScan systems

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Combination of two targeted therapies increases survival in advanced melanoma

Combination of two targeted therapies increases survival in advanced melanoma

HIV cure research may shift from single-therapy development model to combination therapy trials

HIV cure research may shift from single-therapy development model to combination therapy trials

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Stanford researchers successfully defeat C. difficile bacteria

Stanford researchers successfully defeat C. difficile bacteria

Researchers develop promising metal-based compound to fight kidney cancer

Researchers develop promising metal-based compound to fight kidney cancer

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

Innovative way may stop spread of glioblastoma multiforme

Innovative way may stop spread of glioblastoma multiforme

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

BWH, DFCI researchers receive $10 million to test effectiveness of aspirin in women with breast cancer

BGB324 shows enhanced tumour clearance in mouse carcinoma models

BGB324 shows enhanced tumour clearance in mouse carcinoma models

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

Glide Technologies, Cilian collaborate to develop solid dose formulation of recombinant influenza vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.